Back to Search
Start Over
Genital Immune Cell Activation and Tenofovir Gel Efficacy: A Case-Control Study.
- Source :
-
Clinical Infectious Diseases . 9/15/2022, Vol. 75 Issue 6, p1088-1091. 4p. - Publication Year :
- 2022
-
Abstract
- Genital inflammation (GI) undermines topical human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) efficacy through unknown mechanisms. Here, associations between activated endocervical CD4 + T-cell numbers and higher deoxyadenosine triphosphate (dATP) concentrations suggest that competition for intracellular metabolites within HIV target cells may reduce the efficacy of antiretroviral-based PrEP in women with GI. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 75
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 159422825
- Full Text :
- https://doi.org/10.1093/cid/ciac115